UK and EU officials conclude AstraZeneca may have blood clot side effects
Share - WeChat

On Wednesday, the European Medicines Agency concluded that the Oxford/AstraZeneca COVID-19 vaccine may cause blood clots. England's Medicines and Healthcare products Regulatory Agency recommended that people under 30 should not receive this type of the vaccine.
Most Viewed in 24 Hours